SER Insider Trading Activity and SEC Form 4 Filings
SER insider trading summary
Over the past 12 months, insiders at Serina Therapeutics, Inc. (SER) reported 22 sales worth $375K by 1 insider and 7 open-market purchases worth $78K by 4 insiders on SEC Form 4. Net insider selling was $298K.
Latest SER insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 7, 2026 | Stephen K. Brannan | Director | Buy | $2K (1,000 @ $2.03) |
| Jun 12, 2026 | Karen J Wilson | Director | Buy | $9K (5,000 @ $1.77) |
| Jun 11, 2026 | Karen J Wilson | Director | Buy | $9K (5,100 @ $1.75) |
| May 22, 2026 | Jay Venkatesan | Director | Buy | $1K (589 @ $1.78) |
| May 22, 2026 | Karen J Wilson | Director | Buy | $19K (10,000 @ $1.93) |
| May 21, 2026 | Karen J Wilson | Director | Buy | $18K (10,000 @ $1.77) |
| May 19, 2026 | Richard Peter Marshall | Director | Buy | $20K (12,183 @ $1.65) |
| Mar 23, 2026 | Randall Moreadith | Chief Scientific Officer | Sell | $19K (6,500 @ $2.86) |
| Mar 19, 2026 | Randall Moreadith | Chief Scientific Officer | Sell | $98K (39,000 @ $2.50) |
| Feb 2, 2026 | Randall Moreadith | Chief Scientific Officer | Sell | $20K (6,500 @ $3.03) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.